The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
Sandra Dupouy, Véronique Viardot-Foucault, Marco Alifano et al. · 2009
Read The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression by Sandra Dupouy, Véronique Viardot-Foucault, Marco Alifano et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004223.txt.
Description
Sandra Dupouy and colleagues published this breast cancer study in PLOS ONE in 2009. Neurotensin is a small signalling molecule, and its high-affinity receptor, NTSR1, had been proposed as one of the factors driving tumour progression. In breast cancer cells, the switched-on receptor coordinates growth signals.
The team examined the neurotensin receptor-1 pathway in human ductal breast cancer, the most common form of the disease. They report that this pathway contributes to the cancer's progression. A pathway that helps a tumour advance is also a pathway that drugs might block. Ductal breast cancer starts in the milk ducts of the breast.
Catalog record
| CREATOR | Sandra Dupouy, Véronique Viardot-Foucault, Marco Alifano et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004223